Brucellosis: a re-emerging zoonosis.
Brucellosis, especially caused by Brucella melitensis, remains one of the most common zoonotic diseases worldwide with more than 500,000 human cases reported annually. The bacterial pathogen is classified by the CDC as a category (B) pathogen that has potential for development as a bio-weapon. Brucella spp. are considered as the most common laboratory-acquired pathogens. The geographical distribution of brucellosis is constantly changing with new foci emerging or re-emerging. The disease occurs worldwide in both animals and humans, except in those countries where bovine brucellosis has been eradicated. The worldwide economic losses due to brucellosis are extensive not only in animal production but also in human health. Although a number of successful vaccines are being used for immunization of animals, no satisfactory vaccine against human brucellosis is available. When the incidence of brucellosis is controlled in the animal reservoirs, there is a corresponding and significant decline in the incidence in humans.
Seleem
Mohamed N
MN
The Institute for Critical Technology and Applied Science, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA.
Boyle
Stephen M
SM
Sriranganathan
Nammalwar
N
D000818:Animals; D002004:Brucella Vaccine / Q000276:immunology; D017347:Brucella melitensis / Q000302:isolation & purification*; D002006:Brucellosis / Q000191:economics / Q000453:epidemiology* / Q000517:prevention & control / Q000662:veterinary*; D021821:Communicable Diseases, Emerging / Q000191:economics / Q000453:epidemiology* / Q000382:microbiology / Q000662:veterinary*; D006801:Humans; D015994:Incidence
D002004:Brucella Vaccine